Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Drug-resistant infections.

Книги з теми "Drug-resistant infections"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 книг для дослідження на тему "Drug-resistant infections".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте книги для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Gillespie, Stephen H., ed. Management of Multiple Drug-Resistant Infections. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-738-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

H, Gillespie S., ed. Management of multiple drug-resistant infections. Humana Press, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Pogorzelska, Monika. Institutional and Patient Level Predictors of Multi-Drug Resistant Healthcare-Associated Infections. [publisher not identified], 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

West, Katherine H. The new threat of drug-resistant microbes: The return of untreatable common infections? 2nd ed. Western Schools Press, 1994.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. World Health Organization, Stop TB Department, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Ernesto, Jaramillo, Stop TB Initiative (World Health Organization), Great Britain. Dept. for International Development., and United States. Agency for International Development., eds. Guidelines for the programmatic management of drug-resistant tuberculosis: [emergency update 2008]. World Health Organization, Stop TB Department, 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Zumla, Alimuddin, David S. C. Hui, and Wing-Wai Yew. Emerging respiratory infections in the 21st century. Saunders, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

A, Weigelt John, ed. MRSA. 2nd ed. Informa Healthcare, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

A, Miller Debra, ed. Resistant infections. Greenhaven Press, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

World Health Organization (WHO). Management of MDR-TB: A field guide, a companion document to Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
11

File, Thomas. New insights in the treatment of severe infections in the multiple-drug resistant situation: Proceedings of a satellite symposium to the 11th International Congress on Infectious Diseases, Cancun, Mexico, March 5, 2004. Karger, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
12

United States. Congress. House. Committee on Oversight and Government Reform. Drug resistant infections in the community: Consequences for public health : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, November 7, 2007. U.S. G.P.O., 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
13

Emami, Saeed. New quinolones with potential anti-MRSA activity. Nova Science, 2009.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
14

Baddour, Manal M. MRSA (methicillin resistant Staphylococcus Aureus) infections and treatment. Nova Science Publishers, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
15

T, Cafferkey Mary, ed. Methicillin-resistant Staphylococcus aureus: Clinical management and laboratory aspects. M. Dekker, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
16

Organization, World Health, ed. Global tuberculosis control: Surveillance, planning, financing : WHO report, 2004. World Health Organization, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
17

Drug-Resistant Infections. World Bank, Washington, DC, 2017. http://dx.doi.org/10.1596/26707.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
18

Gillespie, Stephen H. Management of Multiple Drug-Resistant Infections (Infectious Disease). Humana Press, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
19

Gillespie, Stephen H. Management of Multiple Drug-resistant Infections. Humana Press Inc.,U.S., 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
20

Gillespie, Stephen H. Management of Multiple Drug-Resistant Infections. Humana Press, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
21

Gillespie, Stephen H. Management of Multiple Drug-Resistant Infections. Island Press, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
22

Harvey, David, and Andrea Ledgerton. Hospital multi-resistant infections. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198745471.003.0007.

Повний текст джерела
Анотація:
This chapter outlines common pathogens responsible for neonatal infections. It describes the processes that should be undertaken when dealing with a hospital outbreak caused by a multi-drug-resistant organism, including understanding the clinical picture, epidemiology, and laboratory results to control the outbreak. The tools and control measures required to manage a hospital outbreak caused by a multi-drug resistant organism are described. Some of the challenges in managing a hospital outbreak caused by a multi-drug resistant organism are outlined and briefly discussed. Outbreaks in neonatal
Стилі APA, Harvard, Vancouver, ISO та ін.
23

Committee on Oversight and Gove (house), United States House of Representatives, and United States United States Congress. Drug Resistant Infections in the Community: Consequences for Public Health. Independently Published, 2019.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
24

The new threat of drug-resistant microbes: The return of untreatable common infections? 4th ed. Western Schools Press, 2000.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
25

The new threat of drug-resistant microbes: The return of untreatable common infections? 3rd ed. Western Schools Press, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
26

The home encyclopedia of herbal medicine: Natural remedies for emerging and drug-resistant infections. Rodale, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
27

Billioux, Alexander. Infections in the Transplant Patient. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0056.

Повний текст джерела
Анотація:
Recipients of donor-derived tissues and organs are at particularly high risk of infection because of their unique combination of risk factors. Chronic illness results in more exposure to health care contexts in which pathogens—especially drug-resistant species—might be acquired. The transplant surgery itself compromises anatomical barriers to infection via indwelling venous and urinary catheters, endotracheal tubes, and surgical wounds. Donor-derived tissues and organs may harbor infectious pathogens undetected during rapid pre-transplant evaluations. The immunosuppression necessary to prevent
Стилі APA, Harvard, Vancouver, ISO та ін.
28

Wilker, Ian, and Evelyn B. Kelly. Tuberculosis and Superbugs: Examining TB and Bacterial Infections. Enslow Publishing, LLC, 2014.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
29

Day, Nancy. Killer Superbugs: The Story of Drug-Resistant Diseases (Issues in Focus). Enslow Publishers, 2001.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
30

Kaushik, Sanket, and Nagendra Singh, eds. Current Developments in the Detection and Control of Multi Drug Resistance. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150498791220101.

Повний текст джерела
Анотація:
The rise in the incidence of infections is caused by multi drug resistant (MDR) bacteria, it is essential to elucidate the basic mechanism of antibiotic resistance to discover effective methods for diagnosis and treatment of infections. The use of pathogen-specific probes offers a faster alternative for pathogen detection and could improve the diagnosis of infection. High resolution melting analysis techniques are useful for the detection of multi drug resistant pathogens. Rational Structural Based Drug Design is a common method to identify a lead compound and take it forward for further devel
Стилі APA, Harvard, Vancouver, ISO та ін.
31

Challenges in Infectious Diseases Emerging Infectious Diseases of the 21st Century. Springer, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
32

Weigelt, John A. MRSA. Taylor & Francis Group, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
33

Weigelt, John A. MRSA. Taylor & Francis Group, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
34

Weigelt, John A. MRSA. Taylor & Francis Group, 2007.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
35

Damani, Nizam. Manual of Infection Prevention and Control. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198815938.001.0001.

Повний текст джерела
Анотація:
The Manual of Infection Prevention and Control provides practical guidance on all aspects of healthcare-associated infections (HAIs). It outlines the basic concepts of infection prevention and control (IPC), modes of transmission, surveillance, control of outbreaks, epidemiology, and biostatistics. The book provides up-to-date advice on the triage and isolation of patients and on new and emerging infectious diseases, and with the use of illustrations, it provides a step-by-step approach on how to perform hand hygiene and how to don and take off personal protective equipment correctly. In addit
Стилі APA, Harvard, Vancouver, ISO та ін.
36

Wilson, Ezekiel. Drug Resistant Infectious Diseases: Ethical Issues. Murphy & Moore Publishing, 2021.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
37

File, T. M. Jr. New Insights in the Treatment of Severe Infections in the Multiple-Drug Resistant Situation: Satellite Symposium to the 11th International Congress on ... March 2004: Proceedings (Chemotherapy). Not Avail, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
38

Barnes, Sheila. Herbal Antivirals: An Easy to Follow Complete Guide on How to Quickly Get Rid of Drug-Resistant Viral Infections and Detox the System Using Natural Antiviral Herbs and Herbal Recipes. Independently Published, 2020.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
39

Drug resistant infections in the community: Consequences for public health : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, November 7, 2007. U.S. G.P.O., 2008.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
40

Management of Drug Resistant HIV (Infectious Disease and Therapy). Marcel Dekker Inc, 2006.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
41

Hopkins, Susan. The international and national challenges faced in ensuring prudent use of antibiotics. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198758792.003.0001.

Повний текст джерела
Анотація:
In April 2014, the World Health Organization reinforced that without urgent coordinated action by most stakeholders the world is headed for a post-antibiotic era in which common infections and minor injuries, which have been treatable for decades, could kill once again. With the rise in the number of infections due to antibiotic-resistant bacteria and the lack of development of new antibiotics, antimicrobial resistance is a major clinical and public health issue that society needs to tackle. This chapter focuses on the challenges of drug resistance and antimicrobial development together with h
Стилі APA, Harvard, Vancouver, ISO та ін.
42

Jacobs, Samantha E., Catherine B. Small, and Thomas J. Walsh. Fungal diseases of the respiratory tract. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0030.

Повний текст джерела
Анотація:
Fungal respiratory infections are important causes of morbidity and mortality in immunocompromised patients. Invasive aspergillosis remains the most common invasive fungal infection whereas other filamentous fungi, such as Fusarium spp., Mucorales, and Scedosporium spp., are increasing in frequency, particularly in neutropenic hosts. Endemic mycoses, including those due to Histoplasma capsulatum, Coccidioides spp., and Talaromyces marneffei, are increasingly prevalent in patients with cell-mediated immunodeficiencies in respective geographic regions. Culture remains the gold standard of diagno
Стилі APA, Harvard, Vancouver, ISO та ін.
43

Buhner, Stephen Harrod. Herbal Antivirals: Natural Remedies for Emerging and Resistant Viral Infections. Storey Publishing, LLC, 2013.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
44

Paterson, David L., and Yoshiro Hayashi. Antimicrobial selection policies in the ICU. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0286.

Повний текст джерела
Анотація:
Antibiotic selection is a crucial drug choice in critically-ill patients. Optimization of empiric antibiotic choice can be gained by knowledge of the site of infection and the probable causative organisms at that site. This should be linked with knowledge of the local epidemiology of antibiotic resistance in the actual intensive care unit housing the patient. Initial empiric antimicrobial choice may need to be broad in order to cover potential antibiotic-resistant pathogens. However, it is important to be prudent in antibiotic strategy since the selection of multiple-resistant organisms by exc
Стилі APA, Harvard, Vancouver, ISO та ін.
45

Levitt, Alexandra M. Deadly Outbreaks: How Medical Detectives Save Lives Threatened by Killer Pandemics, Exotic Viruses, and Drug-Resistant Parasites. Skyhorse Publishing Company, Incorporated, 2013.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
46

Hopkins, Donald R., and Alexandra M. Levitt. Deadly Outbreaks: How Medical Detectives Save Lives Threatened by Killer Pandemics, Exotic Viruses, and Drug-Resistant Parasites. Skyhorse Publishing Company, Incorporated, 2015.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
47

Hopkins, Donald R., and Alexandra M. Levitt. Deadly Outbreaks: How Medical Detectives Save Lives Threatened by Killer Pandemics, Exotic Viruses, and Drug-Resistant Parasites. Skyhorse Publishing Company, Incorporated, 2015.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
48

Russell, Georgina, and Onn Min Kon. Tuberculosis. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0022.

Повний текст джерела
Анотація:
Tuberculosis is an important infection globally, with 1.45 million deaths attributed to tuberculosis in 2010 by the World Health Organization. Respiratory physicians need to be familiar with the varied presentations and management of this disease. In addition, the proportion of cases now presenting with extrapulmonary disease are approximately half of all cases, and of particular relevance is mediastinal node tuberculosis which represents about 10% of all cases of tuberculosis in the United Kingdom. This chapter presents the case of a patient with miliary tuberculosis who developed significant
Стилі APA, Harvard, Vancouver, ISO та ін.
49

Callahan, Joan R. Emerging Biological Threats. ABC-CLIO, LLC, 2009. http://dx.doi.org/10.5040/9798400645020.

Повний текст джерела
Анотація:
An engaging, nontechnical discussion of the infectious diseases and other biological threats that pose the highest risk to humans, presented in the context of relevant environmental and sociological trends. What biological agents should we truly be afraid of? Which have garnered more attention than they warrant? Emerging Biological Threats: A Reference Guide is the antidote for the confusion surrounding the potentially devastating impact of pathogens on the human community. Written by a frontline professional in epidemiology, it is the most authoritative yet engagingly written resource availab
Стилі APA, Harvard, Vancouver, ISO та ін.
50

McGregor, Laura, Monica N. Gupta, and Max Field. Septic arthritis in adults. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0098.

Повний текст джерела
Анотація:
Septic arthritis (SA) is a medical emergency with mortality of around 15%. Presentation is usually monoarticular but in more than 10% SA affects two or more joints. Symptoms include rapid-onset joint inflammation with systemic inflammatory responses but fever and leucocytosis may be absent at presentation. Treatment according to British Society of Rheumatology/British Orthopaedic Association (BSR/BOA) guidelines should be commenced if there is a suspicion of SA. At-risk patients include those with primary joint disease, previous SA, recent intra-articular surgery, exogenous sources of infectio
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!